Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

[A case of Complete Response(CR)to combination therapy of S-1 and Gemcitabine(GEM)for unresectable pancreatic cancer].

Miyagawa K, Yata Y, Yamaoka N, Sagara Y.

Gan To Kagaku Ryoho. 2010 Jun;37(6):1145-7. Japanese.

PMID:
20567125
2.

[A case of advanced pancreatic cancer responding well to S-1/gemcitabine combination therapy after gemcitabine therapy].

Kuji M, Yamamoto Y, Tani C, Kenno S, Kobayashi T.

Gan To Kagaku Ryoho. 2011 May;38(5):853-5. Japanese.

PMID:
21566453
3.

[S-1+gemcitabine (GEM) therapy was effective in a case of unresectable pancreatic head carcinoma].

Takada J, Okuda K, Kenno S, Shimada S, Oba G, Shimokuni T, Aoki T, Hamada H.

Gan To Kagaku Ryoho. 2008 Nov;35(12):2120-2. Japanese.

PMID:
19106543
4.
5.

[S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis].

Fukui H, Kou C, Matsumoto T, Matsumoto M.

Gan To Kagaku Ryoho. 2010 Sep;37(9):1775-8. Japanese.

PMID:
20841945
6.

[Gemcitabine in combination with S-1 or UFT in patients with advanced pancreatic cancer].

Sasajima J, Tanno S, Koizumi K, Nakano Y, Habiro A, Chiba A, Fujii T, Sugiyama Y, Nakamura K, Nishikawa T, Mizukami Y, Okumura T, Kohgo Y.

Gan To Kagaku Ryoho. 2009 Oct;36(10):1657-61. Japanese.

PMID:
19838023
7.

Retrospective study of gemcitabine plus S-1 versus gemcitabine alone in cases with unresectable advanced pancreatic cancer.

Suzuki S, Ozaki Y, Saida S, Kaji S, Koike N, Harada N, Hayashi T, Suzuki M.

Hepatogastroenterology. 2013 Jun;60(124):916-20. doi: 10.5754/hge121235. Epub 2013 Mar 11.

PMID:
23478143
8.

Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.

Li Y, Sun J, Jiang Z, Zhang L, Liu G.

J Chemother. 2015 Aug;27(4):227-34. doi: 10.1179/1973947815Y.0000000013. Epub 2015 Mar 20.

PMID:
25790948
9.

[A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].

Nishimizu T, Minemura M, Kajiura S, Tokimitsu Y, Itaya Y, Yamawaki H, Kawai K, Tajiri K, Nakayama Y, Hosokawa A, Takahara T, Yasumura S, Shimizu S, Fukuoka J, Ishizawa S, Sawasaki T, Yanagisawa A, Sugiyama T.

Gan To Kagaku Ryoho. 2011 Feb;38(2):309-12. Japanese.

PMID:
21368502
10.

[Clinical benefit of full-dose gemcitabine for advanced pancreatic cancer refractory to S-1+gemcitabine].

Hachisuka H, Takahashi M, Kushima A, Nakamoto T, Takahashi K, Iwamura Y, Wakata M, Nagano K, Nakajima T, Nunomura M, Araki K.

Gan To Kagaku Ryoho. 2013 May;40(5):639-42. Japanese.

PMID:
23863590
11.

[A partial response to S-1 as second-line chemotherapy in a patient with unresectable pancreatic cancer].

Egawa T, Ohashi M, Ito Y, Mihara K, Takahashi T, Hayashi S, Nagashima A.

Gan To Kagaku Ryoho. 2009 Nov;36(12):2422-4. Japanese.

PMID:
20037443
12.

Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer.

Kawashima H, Itoh A, Ohno E, Nakamura M, Miyahara R, Ohmiya N, Hara K, Kanamori A, Itoh T, Taki T, Hirai T, Hashimoto S, Takeda K, Goto H, Hirooka Y.

Cancer Chemother Pharmacol. 2011 Sep;68(3):677-83. doi: 10.1007/s00280-010-1531-6. Epub 2010 Dec 5.

PMID:
21132496
13.

[Usefulness of S-1/gemcitabine combination therapy for advanced pancreatic cancer].

Hara T, Nagata M, Yamashita Y, Fujimoto K, Muraki Y, Yasuda Y, Kurahashi T.

Gan To Kagaku Ryoho. 2008 Jul;35(7):1233-7. Japanese.

PMID:
18633271
14.

[A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].

Hatata T, Takaya S, Taniguchi K, Naka T, Kondo A, Ikeguchi M.

Gan To Kagaku Ryoho. 2011 Jan;38(1):109-12. Japanese.

PMID:
21368469
15.

[Treatments of pancreatic cancer from the standpoint of medical oncology].

Furuse J, Ishii H, Nakachi K, Suzuki E, Shimizu S.

Gan To Kagaku Ryoho. 2007 Jul;34(7):997-1001. Review. Japanese.

PMID:
17637534
16.

[A case of recurrent pancreatic cancer with lung metastasis responding to S-1 combined gemcitabine chemotherapy].

Fukada I, Ikeda H, Yamaguchi K, Okabe M, Tsuruta A, Morimoto Y, Kawamoto K, Sano K, Paku T, Imai S, Yoshida Y, Ito T, Ogasahara K.

Gan To Kagaku Ryoho. 2009 Oct;36(10):1733-6. Japanese.

PMID:
19838037
17.

Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer.

Nakata B, Amano R, Nakao S, Tamura T, Shinto O, Hirakawa T, Okita Y, Yamada N, Hirakawa K.

J Exp Clin Cancer Res. 2010 Feb 24;29:15. doi: 10.1186/1756-9966-29-15.

18.

[Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy].

Sato Y, Tsuchiya Y, Aizawa M, Nomura T, Nashimoto A.

Gan To Kagaku Ryoho. 2014 Sep;41(9):1151-4. Japanese.

PMID:
25248901
19.

[A case of locally advanced pancreas cancer effectively treated by multidisciplinary strategy].

Hasegawa K, Katsuta E, Iwata N, Aoyagi H, Yoshida T, Takahata T, Kaneko J, Maejima S.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2152-4. Japanese.

PMID:
22202313
20.

[A case of curatively resected locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemotherapy].

Okada T, Sakurai N, Yamamoto K, Motoi F, Kakizaki Y, Tamura G, Unno M, Iizawa H.

Gan To Kagaku Ryoho. 2012 Jan;39(1):135-7. Japanese.

PMID:
22241369

Supplemental Content

Support Center